Cipla partners with Kemwell and Manipal for innovative cell therapy products worldwide

Under this strategic alliance, Cipla (EU) is set to secure a 35.2% stake in the joint venture company. Shares of Cipla Ltd ended at ₹1,271.05, down by ₹15.45, or 1.20%, on the BSE.

Related Keywords

United States ,India ,Manipal ,Karnataka ,Mauritius ,Japan ,Bengaluru ,Anurag Bagaria ,Ranjan Pai ,Shoma Bhattacharjee ,Umang Vohra ,Cipla Ltd On Monday ,Manipal Education Medical Group ,Kemwell Biopharma Private Ltd ,Cipla ,Kemwell Biopharma United Kingdom Ltd ,Cipla Ltd ,Cipla Eu Ltd ,Manipal Education ,Medical Group ,Managing Director ,Global Chief Executive Officer ,Cipla Bse Share Price Today ,Cipla Shares ,Cipla Stock Price ,Cipla Share Price ,Kemwell Biopharma Private ,Emwell Biopharma Uk ,Anipal Education Amp Medical Group ,Jani Ventures ,Cell Therapy Products , ,